Lotsberg et al. reported that a small molecule inhibitor bemcentinib inhibits the transcription of autophagy-associated genes, releases DAMPs and then gives rise to ICD in NSCLC cells by targeted inhibition of the AXL signaling pathway (164). Here, AXL is linked to non-small cell lung carcinoma.